RxDoctor Payments Data

Masahiro Horikawa, MD

Vascular & Interventional Radiology · Portland, ORNPI 1538587118

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (32.4%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Boston Scientific at 37.8% of the total. Reporting peaked in 2024 at $9,997 and has fallen 66.4% since, to $3,356 in 2025.

$24,897in general payments, 2019–2025

Across 123 payments — averaging $202.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$9K
  • Inari Medical, Inc.$7K
  • Kaneka Medical America LLC$3K
  • Terumo Medical Corporation$2K
  • Penumbra, Inc.$1K
  • Stryker$980
  • plus $1K from 8 others

What the payments were for

  • Consulting fees$3,46414%
  • Speaking & faculty fees$7,59831%
  • Travel & lodging$5,77923%
  • Food & beverage$8,05632%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,897 in reported general payments places this provider in the 85th percentile of 73 vascular & interventional radiology providers in Oregon.

See all vascular & interventional radiology providers in Oregon

Medicare billing

Part B allowed, 2024
$43,567
Medicare patients
77
Services billed
243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone18$130
Oxycodone Hcl21$89

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →